Healthcare Triage News: Knee Surgery Doesn’t Improve Outcomes, but We Still Do A LOT of Them

Healthcare Triage News: Knee Surgery Doesn’t Improve Outcomes, but We Still Do A LOT of Them

Image result for Healthcare Triage News: Knee Surgery Doesn’t Improve Outcomes, but We Still Do A LOT of Them

The news tells us that arthroscopic surgery for knee arthritis and meniscal tears isn’t worth it. Healthcare Triage told you that a while ago. What’s new? This is Healthcare Triage News.

 

Septicemia still tops the list of most expensive inpatient conditions

http://www.fiercehealthcare.com/healthcare/septicemia-still-tops-most-expensive-conditions?utm_medium=nl&utm_source=internal&mrkid=959610&mkt_tok=eyJpIjoiTnpjME9EY3hNV0k1T0dReSIsInQiOiJ5SjZJckh1d29TRXJyNk92aDRnOFc5V1ZiSFpCN1hJVFdYNDVuMjJjZ3czY0h4cm8rNDVUSXRkRE5tcnBwanlvaFdyZHRBdG1WMUoya1MraXJlQzJOeE5qR3c1Q24wYWc1SXF0Zk5UOWFvND0ifQ%3D%3D

hospital

Septicemia continues to top a list of the most expensive inpatient conditions, according to a new report from the Association for Healthcare Research and Quality’s Healthcare Cost and Utilization Project.

http://www.hcup-us.ahrq.gov/reports/statbriefs/sb204-Most-Expensive-Hospital-Conditions.jsp?utm_source=AHRQ&utm_medium=AHRQSTAT&utm_content=Content&utm_term=HCUP&utm_campaign=AHRQ_SB_204_2016

 

Cartiva closes out $8M Series D to bring its synthetic cartilage product geared at osteoarthritis to U.S. market

Cartiva closes out $8M Series D to bring its synthetic cartilage product geared at osteoarthritis to U.S. market

cartiva